(1r,4S)-4-(aminomethyl)-N-((S)-3-(2'-methyl-4'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)-1-oxo-1-(3-oxo-2,3-dihydro-1H-indazol-6-ylamino)propan-2-yl)cyclohexanecarboxamide

ID: ALA4539788

PubChem CID: 117986252

Max Phase: Preclinical

Molecular Formula: C35H42N6O5S

Molecular Weight: 658.82

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(S(=O)(=O)N2CCCC2)ccc1-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2ccc3c(=O)[nH][nH]c3c2)cc1

Standard InChI:  InChI=1S/C35H42N6O5S/c1-22-18-28(47(45,46)41-16-2-3-17-41)13-15-29(22)25-8-4-23(5-9-25)19-32(38-33(42)26-10-6-24(21-36)7-11-26)35(44)37-27-12-14-30-31(20-27)39-40-34(30)43/h4-5,8-9,12-15,18,20,24,26,32H,2-3,6-7,10-11,16-17,19,21,36H2,1H3,(H,37,44)(H,38,42)(H2,39,40,43)/t24-,26-,32-/m0/s1

Standard InChI Key:  YKEUPPOASIWEHM-BAMJFLLESA-N

Molfile:  

 
     RDKit          2D

 47 52  0  0  0  0  0  0  0  0999 V2000
   35.4983   -7.6189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0938   -8.3287    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.9108   -8.3241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0239   -5.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0239   -6.7026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7292   -7.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4344   -6.7026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4344   -5.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7292   -5.4727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7292   -4.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4369   -4.2469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.0215   -4.2469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.1446   -4.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8523   -4.2469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5600   -4.6555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8523   -3.4297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.1446   -5.4727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8523   -5.8813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8483   -6.6996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5552   -7.1081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2638   -6.6994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2612   -5.8780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5538   -5.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9710   -7.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9708   -7.9253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6782   -8.3329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3863   -7.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3826   -7.1019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6746   -6.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6713   -5.8809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2677   -4.2469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7292   -7.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0215   -8.3329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9744   -4.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2651   -3.4352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6775   -4.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9694   -3.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6803   -3.4278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2831   -2.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9448   -2.1324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.1330   -2.2244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0838   -3.0398    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0973   -9.1472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4414   -9.6282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6960  -10.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5132  -10.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7636   -9.6247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  6
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 13 17  1  6
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 21 24  1  0
 29 30  1  0
 15 31  1  0
  6 32  1  1
 32 33  1  0
 31 34  2  0
 34 36  1  0
 37 35  2  0
 35 31  1  0
 38 36  2  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 37  1  0
 39 42  2  0
 27  2  1  0
  2 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 43  1  0
M  END

Associated Targets(Human)

PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F11 Tchem Coagulation factor XI (1733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 658.82Molecular Weight (Monoisotopic): 658.2937AlogP: 4.05#Rotatable Bonds: 10
Polar Surface Area: 170.25Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.76CX Basic pKa: 10.40CX LogP: 3.79CX LogD: 1.91
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.17Np Likeness Score: -1.23

References

1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA..  (2020)  Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.,  63  (4): [PMID:31658420] [10.1021/acs.jmedchem.9b01060]

Source